Irving J. Zamora

Irving J. Zamora

Auto-generated profile, based on publicly available information

Irving J. Zamora

Department of Pediatric Surgery, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2021 in Cancers
Verified
Journal Article
Open access
PDF file
IZIoannis A. Ziogas
Ioannis A. Ziogas
IZIrving J. Zamora
Irving J. Zamora
Harold LovvornHarold Lovvorn
Harold Lovvorn
CBChristina E. Bailey
Christina E. Bailey
SASophoclis Alexopoulos
Sophoclis Alexopoulos
This study evaluates the clinicopathological characteristics and outcomes of children vs. adults with undifferentiated embryonal sarcoma of the liver (UESL). A retrospective analysis of 82 children (<18 years) and 41 adults (≥18 years) with UESL registered in the National Cancer Database between 2004–2015 was conducted. No between-group differences were observed regarding tumor size, metastasis, surgical treatment, margin status, and radiation. Children received chemotherapy more often than adults (92.7% vs. 65.9%; p < 0.001). Children demonstrated superior overall survival vs. adults (log-rank, p < 0.001) with 5-year rates of 84.4% vs. 48.2%, respectively. In multivariable Cox regression for all patients, adults demonstrated an increased risk of mortality compared to children (p < 0.001), while metastasis was associated with an increased (p = 0.02) and surgical treatment with a decreased (p = 0.001) risk of mortality. In multivariable Cox regression for surgically-treated patients, adulthood (p = 0.004) and margin-positive resection (p = 0.03) were independently associated with an increased risk of mortality. Multimodal treatment including complete surgical resection and chemotherapy results in long-term survival in most children with UESL. However, adults with UESL have poorer long-term survival that may reflect differences in disease biology and an opportunity to further refine currently available treatment schemas.

21 October 2023 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
JRJessica Rauh
Jessica Rauh
GDGoeto Dantes
Goeto Dantes
MWMarshall Wallace
Marshall Wallace
ACAmelia Collings
Amelia Collings
GSGloria D. Sanin
Gloria D. Sanin
LNLucas P. Neff
Lucas P. Neff

5 January 2024 in Seminars in Pediatric Surgery
Verified
Journal Article
Open access
JSJohn Sincavage
John Sincavage
BGBrian C. Gulack
Brian C. Gulack
IZIrving J. Zamora
Irving J. Zamora
The breadth of pediatric surgical practice and variety of anatomic anomalies that characterize surgical disease in children and neonates require a unique level of operative mastery and versatility. Intraoperative navigation of small, complex, and often abnormal anatomy presents a particular challenge for pediatric surgeons. Clinical experience with fluorescent tissue dye, specifically indocyanine green (ICG), is quickly gaining widespread incorporation into adult surgical practice as a safe, non-toxic means of accurately visualizing tissue perfusion, lymphatic flow, and biliary anatomy to enhance operative speed, safety, and patient outcomes. Experience in pediatric surgery, however, remains limited. ICG-fluorescence guided surgery is poised to address the challenges of pediatric and neonatal operations for a growing breadth of surgical pathology. Fluorescent angiography has permitted intraoperative visualization of colorectal flap perfusion for complex pelvic reconstruction and anastomotic perfusion after esophageal atresia repair, while its hepatic absorption and biliary excretion has made it an excellent agent for delineating the dissection plane in the Kasai portoenterostomy and identifying both primary and metastatic hepatoblastoma lesions. Subcutaneous and intra-lymphatic ICG injection can identify iatrogenic chylous leaks and improved yields in sentinel lymph node biopsies. ICG-guided surgery holds promise for more widespread use in pediatric surgical conditions, and continued evaluation of efficacy will be necessary to better inform clinical practice and identify where to focus and develop this technical resource.

29 May 2022 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
LELauren L. Evans
Lauren L. Evans
CCCaressa S. Chen
Caressa S. Chen
OMOliver J. Muensterer
Oliver J. Muensterer
MSMohammad Sahlabadi
Mohammad Sahlabadi
HLHarold N. Lovvorn
Harold N. Lovvorn
IZIrving J. Zamora
Irving J. Zamora

10 September 2024 in Journal of Surgical Research
Verified
Journal Article
Closed access
MWMarshall W. Wallace
Marshall W. Wallace
CRChirag Ram
Chirag Ram
AMAlexander Mina
Alexander Mina
HLHarold N. Lovvorn
Harold N. Lovvorn
APAnuradha Patel
Anuradha Patel
IZIrving J. Zamora
Irving J. Zamora

24 September 2024 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
GRGarrett Reid
Garrett Reid
JRJessica L. Rauh
Jessica L. Rauh
EWElizabeth Wood
Elizabeth Wood
GDGoeto Dantes
Goeto Dantes
MSMatthew T. Santore
Matthew T. Santore
HAHanna Alemayehu
Hanna Alemayehu